| Toyen Yoshizuka, PA-C | |
|
101 The City Dr S, Orange, CA 92868-3201 | |
| (714) 456-7890 | |
| Not Available |
| Full Name | Toyen Yoshizuka |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 4 Years |
| Location | 101 The City Dr S, Orange, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013510825 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | PA63699 (California) | Primary |
| 363A00000X | Physician Assistant | 0010-10766 (North Carolina) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Duke University Hospital | Durham, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Duke University Health System Inc | 2567372345 | 837 |
News Archive
Watson Pharmaceuticals, Inc. today announced an agreement to expand their Women's Health brand product portfolio with the acquisition of the exclusive U.S. rights to Columbia Laboratories, Inc.'s bioadhesive progesterone gel products currently marketed under the trade names CRINONE® and PROCHIEVE® for the indications of infertility and secondary amenorrhea.
AP-HP Greater Paris University Hospitals, the leading European clinical trial center with the largest amount of healthcare data in France dedicated to research and Owkin, a startup pioneering Federated Learning and AI technologies for medical research and clinical development, announced the recent results of their ongoing strategic collaboration at ASCO 2021.
Patients with atrial fibrillation and declining renal function are at increased risk of subsequent stroke or systemic embolism, major bleeding and death, US researchers report.
Patients with asthma who are black appear more likely to visit the emergency department or be hospitalized for the condition than those who are white, even in a managed care setting that provides uniform access to care, according to a report in the September 24 issue of Archives of Internal Medicine.
Allos Therapeutics, Inc. today announced that it has submitted a request to the European Medicines Agency (EMA) for a re-examination of the negative opinion issued in January by the EMA's Committee For Medicinal Products for Human Use (CHMP) for conditional approval of FOLOTYN (pralatrexate injection) for the treatment of patients with peripheral T-cell lymphoma (PTCL) whose disease has progressed after at least one prior systemic therapy.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Toyen Yoshizuka, PA-C 101 The City Dr S, Orange, CA 92868-3201 Ph: () - | Toyen Yoshizuka, PA-C 101 The City Dr S, Orange, CA 92868-3201 Ph: (714) 456-7890 |
News Archive
Watson Pharmaceuticals, Inc. today announced an agreement to expand their Women's Health brand product portfolio with the acquisition of the exclusive U.S. rights to Columbia Laboratories, Inc.'s bioadhesive progesterone gel products currently marketed under the trade names CRINONE® and PROCHIEVE® for the indications of infertility and secondary amenorrhea.
AP-HP Greater Paris University Hospitals, the leading European clinical trial center with the largest amount of healthcare data in France dedicated to research and Owkin, a startup pioneering Federated Learning and AI technologies for medical research and clinical development, announced the recent results of their ongoing strategic collaboration at ASCO 2021.
Patients with atrial fibrillation and declining renal function are at increased risk of subsequent stroke or systemic embolism, major bleeding and death, US researchers report.
Patients with asthma who are black appear more likely to visit the emergency department or be hospitalized for the condition than those who are white, even in a managed care setting that provides uniform access to care, according to a report in the September 24 issue of Archives of Internal Medicine.
Allos Therapeutics, Inc. today announced that it has submitted a request to the European Medicines Agency (EMA) for a re-examination of the negative opinion issued in January by the EMA's Committee For Medicinal Products for Human Use (CHMP) for conditional approval of FOLOTYN (pralatrexate injection) for the treatment of patients with peripheral T-cell lymphoma (PTCL) whose disease has progressed after at least one prior systemic therapy.
› Verified 4 days ago
Tom Chow, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 280 S Main St, Ste 200, Orange, CA 92868 Phone: 714-634-4567 Fax: 714-634-4569 | |
Kimberly Navarro, PA63196 Physician Assistant Medicare: Medicare Enrolled Practice Location: 725 W La Veta Ave Ste 220, Orange, CA 92868 Phone: 714-771-5700 | |
Tiffany Kim, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 2592 N Santiago Blvd, Orange, CA 92867 Phone: 855-434-7763 Fax: 949-281-5550 | |
Julie Huynh, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 700 S Tustin St, Orange, CA 92866 Phone: 714-633-6373 | |
Jennifer J. Judelson, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1140 W La Veta Ave, Suite 860, Orange, CA 92868 Phone: 714-835-6500 Fax: 714-541-6105 | |
Megan Branum, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 1100 W Town And Country Rd, Orange, CA 92868 Phone: 323-728-7232 |